Purpose: To determine risk factors (RFs) for hemorrhagic adverse events (AEs) associated with percutaneous transhepatic biliary drainage (PTBD) and to develop a risk assessment model.
Materials And Methods: This was a multicenter, prospective, case control study between 2015 and 2020. Adults with an indication for PTBD were included.